Why investing in SPACs is a big gamble
They were always a waste of money, and that reality is dawning. It would be mad to join the party now, says Matthew Lynn.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
It now looks as if investors in London will, just as their US counterparts have for a while, be offered the curious privilege of handing over lots of money to management teams who promise to spend it on some great deals, even if what they are actually going to buy is still kept carefully under wraps.
Marwyn, a London-based sponsor of acquisition companies, has announced plans for a £500m acquisition vehicle to be listed in London.
At the same time, Sky News reported that a £150m acquisition vehicle called Finsac, set up by former executives from KBN and Munich Re, would be listed in London soon. There could be plenty more in the pipeline.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Dodging the bullet
At the height of the boom in Spacs – special purpose acquisition companies that raise millions in capital with the aim purely of buying other companies – in New York, there was plenty of criticism that London was missing out.
As so often in the past, the US market was innovating furiously, while the British one was getting left behind.
There was even a Brexit twist to the tale, as Amsterdam, London’s main rival in the equities industry now that we are out of the EU, managed to list more than 30 Spacs, while the City listed almost none. The LSE tweaked its rules to make it easier, but still no one seemed interested.
The UK might have dodged a bullet. It turns out that Spacs were not such a great idea after all.
Spacs boomed in New York in 2020 and 2021 with billions raised on little more than reputation and promises. In a single year, more than 1,000 shell companies were listed, raising a total of $160bn, with backed by a vague promise to buy something or other sometime one day soon.
The vast majority of them have proved very disappointing. Some of the most high-profile among them, such as the digital-media company BuzzFeed, have delivered terrible results.
An index of post-merger Spacs – that is, the ones that have found and acquired a target – fell by 23% in January alone, a much worse performance than the broader Nasdaq, which fell by just 9% over the same month.
A clutch of companies such as the clean-energy manufacturer Heliogen and the 3D printing start-up Matterport fell by more than 50% over the course of a single month. True, a handful, such as ChargePoint Holdings, have done well.
But the vast majority have floundered, and a worryingly large number have crashed.
A solution in search of a problem
In truth, Spacs are a waste of time and money. If a company wants to come to the market there is nothing wrong with the traditional route – come up with a clear and detailed plan, appoint advisers, issue a prospectus and sell shares. It was perfectly straightforward, and anyone who wanted to invest could make a decision based on the prospects of the business. Spacs were a poor solution to a non-existent problem.
It is hardly surprising that so many have crashed. By raising the capital first, and then trying to find a target, they put themselves in a position where they would inevitably end up wildly overpaying for anything they bought. The founders of most Spacs tried to claim that their contacts and expertise meant they could find fantastic deals that wouldn’t otherwise be available. There was not much evidence of that. In reality, the market is generally very efficient, and there are not many opportunities out there. Entrepreneurs know that they have plenty of options. They can go for a traditional initial public offering. They can sell to a venture-capital or private-equity firm, or they can persuade a bigger company to take them over. The only real reason for selling to a Spac was that it was offering a lot more cash than the business was really worth.
London was lucky to miss out on the Spac boom. Perhaps it was inertia, or laziness, or good fortune. More plausibly, perhaps, the world’s oldest and savviest financial centre simply sensed that it was a scam, and quite rightly stepped back from getting involved. Whatever the explanation, the City has had a lucky escape. And the last thing it should try and do is jump on the bandwagon a year too late.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Matthew Lynn is a columnist for Bloomberg and writes weekly commentary syndicated in papers such as the Daily Telegraph, Die Welt, the Sydney Morning Herald, the South China Morning Post and the Miami Herald. He is also an associate editor of Spectator Business, and a regular contributor to The Spectator. Before that, he worked for the business section of the Sunday Times for ten years.
-
How a ‘great view’ from your home can boost its value by 35%A house that comes with a picturesque backdrop could add tens of thousands of pounds to its asking price – but how does each region compare?
-
What is a care fees annuity and how much does it cost?How we will be cared for in our later years – and how much we are willing to pay for it – are conversations best had as early as possible. One option to cover the cost is a care fees annuity. We look at the pros and cons.
-
Three key winners from the AI boom and beyondJames Harries of the Trojan Global Income Fund picks three promising stocks that transcend the hype of the AI boom
-
RTX Corporation is a strong player in a growth marketRTX Corporation’s order backlog means investors can look forward to years of rising profits
-
Profit from MSCI – the backbone of financeAs an index provider, MSCI is a key part of the global financial system. Its shares look cheap
-
'AI is the real deal – it will change our world in more ways than we can imagine'Interview Rob Arnott of Research Affiliates talks to Andrew Van Sickle about the AI bubble, the impact of tariffs on inflation and the outlook for gold and China
-
Should investors join the rush for venture-capital trusts?Opinion Investors hoping to buy into venture-capital trusts before the end of the tax year may need to move quickly, says David Prosser
-
Food and drinks giants seek an image makeover – here's what they're doingThe global food and drink industry is having to change pace to retain its famous appeal for defensive investors. Who will be the winners?
-
Barings Emerging Europe trust bounces back from Russia woesBarings Emerging Europe trust has added the Middle East and Africa to its mandate, delivering a strong recovery, says Max King
-
How a dovish Federal Reserve could affect youTrump’s pick for the US Federal Reserve is not so much of a yes-man as his rival, but interest rates will still come down quickly, says Cris Sholto Heaton